Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. (EHAB) is a premier provider of home health and hospice services in the United States. Committed to delivering care where patients prefer it most—right in their own homes—Enhabit operates through two main segments: Home Health and Hospice.
The Home Health segment offers a comprehensive range of Medicare-certified nursing services to adults in need of medical care. These services include skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. This segment is the cornerstone of Enhabit’s revenue generation, providing essential healthcare support that fosters improved quality of life and recovery in the comfort of patients’ homes.
The Hospice segment is dedicated to enhancing the quality of life for patients with advanced, life-limiting illnesses. This segment focuses on treating the person and their symptoms, rather than the disease itself, through personalized care plans and compassionate support. It ensures that patients receive comprehensive end-of-life care that prioritizes their comfort and dignity.
With a solid reputation for excellence in home-based healthcare, Enhabit continually strives to advance its services and reach. Recent achievements include strategic partnerships that expand service capabilities and innovative projects aimed at improving patient outcomes. Financially, the company remains robust, consistently investing in cutting-edge healthcare technologies and staff training to maintain high standards of care.
Enhabit’s commitment to patient-centered care, combined with its extensive service offerings, positions it as a significant player in the healthcare industry. For investors and stakeholders seeking the latest updates and performance metrics, staying informed about Enhabit's continuous developments and strategic initiatives is essential.
Enhabit, Inc. (NYSE: EHAB), a prominent home health and hospice provider, announced its participation in the BofA Securities Home Care Conference on December 5, 2022. During the conference, CEO Barbara Jacobsmeyer and CFO Crissy Carlisle will engage in a fireside chat at 9:00 a.m. ET. The event will be available for live streaming on the company's investor relations website. Enhabit operates 250 home health and 100 hospice locations across 34 states, focusing on enhancing patient care through technology and dedicated clinicians.
Enhabit, a national home health and hospice provider, has been recognized in Fortune’s “30 Best Large Workplaces in Health Care” and Modern Healthcare’s “Best Places to Work in Healthcare” awards. The company ranked #23 in Fortune's awards for the eighth consecutive year and #34 in Modern Healthcare's Provider/Insurer category. These accolades reflect Enhabit’s commitment to employee engagement and retention, crucial in the current healthcare labor shortage. Enhabit prioritizes work-life balance, professional development, and competitive benefits for its over 10,000 employees.
Enhabit, Inc. (NYSE: EHAB) announced its participation in the Credit Suisse 31st Annual Healthcare Conference in Palos Verdes, California, on November 8, 2022. President and CEO Barbara Jacobsmeyer, along with CFO Crissy Carlisle, will engage in a fireside chat at 5:00 p.m. ET. This session will be available via a live webcast on the company's investor relations website. Enhabit is a prominent home health and hospice provider, operating 250 home health and 100 hospice locations across 34 states, aiming to enhance patient care at home.
Enhabit, Inc. (NYSE: EHAB) reported its third quarter 2022 results, showing a 3.0% decline in net service revenue to $265.7 million compared to Q3 2021, and a significant 60.2% drop in net income to $8.6 million. Adjusted EBITDA fell 26.3% to $31.7 million. Home health services experienced growth, particularly in Medicare Advantage admissions, up 31.5% year-over-year. However, the company faces challenges from increased labor costs, a shift to non-episodic patients, and lower hospice volumes. Full-year guidance for net service revenue and adjusted EBITDA has been adjusted downward.
Enhabit, Inc. (NYSE: EHAB) will report its third-quarter results for the period ending September 30, 2022, after market close on November 1, 2022. A conference call will be held on November 2, 2022, at 10:00 a.m. Eastern to discuss the results. Interested participants can join by dialing 888-660-6150 (toll-free) or 929-203-0843 (international), with Conference ID: 5248158. The call can be accessed online via Enhabit's investor website.
Enhabit, Inc. (NYSE: EHAB) has acquired Caring Hearts Hospice, a local provider in Texas, effective October 1, 2022. This acquisition enhances Enhabit’s hospice service line by adding four new locations: Gun Barrel City, Mineola, Palestine, and Quinlan, Texas. The company, which ranks as the fourth largest Medicare-certified home health provider and the 12th largest hospice provider in the U.S., aims to expand its national footprint and improve patient care quality.
Enhabit Home Health & Hospice (NYSE: EHAB) announced its participation in key investor events, including the Jefferies Nashville Bus Tour on Aug. 31, 2022, and the Wells Fargo Healthcare Conference in Boston on Sept. 8, 2022. CEO Barbara Jacobsmeyer and CFO Crissy Carlisle will host a fireside chat on Sept. 8 at 4:20 p.m. ET, available via live webcast on their investor page. Enhabit operates 251 home health and 100 hospice locations across 34 states, focusing on innovative patient care solutions.
Enhabit Home Health & Hospice (NYSE: EHAB) reported a 6.3% decline in net service revenue to $268.0 million for Q2 2022, compared to Q2 2021. Net income fell 37.8% to $20.1 million. Adjusted EBITDA decreased 30.3% to $40.3 million, reflecting challenges in the healthcare sector, including labor costs and a shift to non-episodic payor mix. The company revised its full-year guidance, projecting net service revenue between $1,075 to $1,110 million and adjusted EBITDA between $155 to $170 million.
Enhabit Home Health & Hospice (NYSE: EHAB) announced it will report its second-quarter results for the period ending June 30, 2022, after market hours on August 1, 2022. The company will hold its first investor conference call as a publicly traded entity on August 2, 2022, at 11 a.m. ET. Investors can access the call by dialing 888-660-6150 with conference ID 5248158. A live webcast and replay will be available on the company's investor website. Enhabit operates 252 home health and 99 hospice locations across 34 states, focusing on patient-centered care.
Enhabit Home Health & Hospice has successfully completed its spin-off from Encompass Health Corporation, now trading under the ticker symbol EHAB on the NYSE as of July 1, 2022. The company emphasizes its commitment to providing high-quality in-home patient care while leveraging over 20 years of expertise. It operates across 351 locations in 34 states. Additionally, Enhabit appointed Tina L. Brown-Stevenson and Susan A. La Monica to its board, enhancing strategic capabilities. The spin-off allows for greater operational flexibility and focus on patient and investor interests.
FAQ
What is the current stock price of Enhabit (EHAB)?
What is the market cap of Enhabit (EHAB)?
What services does Enhabit, Inc. offer?
Where does Enhabit, Inc. operate?
How does Enhabit, Inc. generate most of its revenue?
What is unique about Enhabit’s Hospice services?
Why might investors be interested in Enhabit, Inc.?
What recent achievements has Enhabit, Inc. made?
How does Enhabit, Inc. ensure high standards of care?
What types of therapy services does Enhabit, Inc. provide?
How can patients benefit from Enhabit’s home health services?
What is the goal of Enhabit’s Hospice care?
